https://www.selleckchem.com/products/grl0617.html
6% in 2013 to 21.1% in 2019. DDD-based usage of the CredibleMeds drugs already listed in 2013 was similar in 2019. Among the drugs with known QT risk according to CredibleMeds , 7.5% (95% CI 2.6-19.9%) of German SmPCs and 21.1% (95% CI 11.1-36.3%) of US PI had no mention of QT issues whatsoever. A significant proportion of all drugs prescribed in the outpatient sector is associated with QT risks according to CredibleMeds . SmPCs and PI should systematically be evaluated for concordance with the widely used CredibleMeds database to incre